Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Isolation and Quantification of Zika Virus from Multiple Organs in a Mouse.

Brien JD, Hassert M, Stone ET, Geerling E, Cruz-Orengo L, Pinto AK.

J Vis Exp. 2019 Aug 15;(150). doi: 10.3791/59632.

PMID:
31475971
2.

Identification of Protective CD8 T Cell Responses in a Mouse Model of Zika Virus Infection.

Hassert M, Harris MG, Brien JD, Pinto AK.

Front Immunol. 2019 Jul 17;10:1678. doi: 10.3389/fimmu.2019.01678. eCollection 2019.

3.

Mouse Models of Heterologous Flavivirus Immunity: A Role for Cross-Reactive T Cells.

Hassert M, Brien JD, Pinto AK.

Front Immunol. 2019 May 9;10:1045. doi: 10.3389/fimmu.2019.01045. eCollection 2019. Review.

4.

CD4+T cells mediate protection against Zika associated severe disease in a mouse model of infection.

Hassert M, Wolf KJ, Schwetye KE, DiPaolo RJ, Brien JD, Pinto AK.

PLoS Pathog. 2018 Sep 13;14(9):e1007237. doi: 10.1371/journal.ppat.1007237. eCollection 2018 Sep.

5.

Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus.

Pantoja P, Pérez-Guzmán EX, Rodríguez IV, White LJ, González O, Serrano C, Giavedoni L, Hodara V, Cruz L, Arana T, Martínez MI, Hassert MA, Brien JD, Pinto AK, de Silva A, Sariol CA.

Nat Commun. 2017 Jun 23;8:15674. doi: 10.1038/ncomms15674.

6.

Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus Infection.

Pinto AK, Brien JD, Lam CY, Johnson S, Chiang C, Hiscott J, Sarathy VV, Barrett AD, Shresta S, Diamond MS.

MBio. 2015 Sep 15;6(5):e01316-15. doi: 10.1128/mBio.01316-15.

7.

Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus.

Smith SA, Silva LA, Fox JM, Flyak AI, Kose N, Sapparapu G, Khomandiak S, Ashbrook AW, Kahle KM, Fong RH, Swayne S, Doranz BJ, McGee CE, Heise MT, Pal P, Brien JD, Austin SK, Diamond MS, Dermody TS, Crowe JE Jr.

Cell Host Microbe. 2015 Jul 8;18(1):86-95. doi: 10.1016/j.chom.2015.06.009. Erratum in: Cell Host Microbe. 2015 Sep 9;18(3):382. Khomadiak, Solomiia [corrected to Khomandiak, Solomiia].

8.

Human and Murine IFIT1 Proteins Do Not Restrict Infection of Negative-Sense RNA Viruses of the Orthomyxoviridae, Bunyaviridae, and Filoviridae Families.

Pinto AK, Williams GD, Szretter KJ, White JP, Proença-Módena JL, Liu G, Olejnik J, Brien JD, Ebihara H, Mühlberger E, Amarasinghe G, Diamond MS, Boon AC.

J Virol. 2015 Sep;89(18):9465-76. doi: 10.1128/JVI.00996-15. Epub 2015 Jul 8.

9.

Propagation, quantification, detection, and storage of West Nile virus.

Brien JD, Lazear HM, Diamond MS.

Curr Protoc Microbiol. 2013 Nov 5;31:15D.3.1-15D.3.18. doi: 10.1002/9780471729259.mc15d03s31.

PMID:
24510289
10.

Chikungunya virus infection results in higher and persistent viral replication in aged rhesus macaques due to defects in anti-viral immunity.

Messaoudi I, Vomaske J, Totonchy T, Kreklywich CN, Haberthur K, Springgay L, Brien JD, Diamond MS, Defilippis VR, Streblow DN.

PLoS Negl Trop Dis. 2013 Jul 25;7(7):e2343. doi: 10.1371/journal.pntd.0002343. Print 2013.

11.

Functional analysis of antibodies against dengue virus type 4 reveals strain-dependent epitope exposure that impacts neutralization and protection.

Sukupolvi-Petty S, Brien JD, Austin SK, Shrestha B, Swayne S, Kahle K, Doranz BJ, Johnson S, Pierson TC, Fremont DH, Diamond MS.

J Virol. 2013 Aug;87(16):8826-42. doi: 10.1128/JVI.01314-13. Epub 2013 Jun 19.

12.

Protection by immunoglobulin dual-affinity retargeting antibodies against dengue virus.

Brien JD, Sukupolvi-Petty S, Williams KL, Lam CY, Schmid MA, Johnson S, Harris E, Diamond MS.

J Virol. 2013 Jul;87(13):7747-53. doi: 10.1128/JVI.00327-13. Epub 2013 May 8.

13.

Development of a highly protective combination monoclonal antibody therapy against Chikungunya virus.

Pal P, Dowd KA, Brien JD, Edeling MA, Gorlatov S, Johnson S, Lee I, Akahata W, Nabel GJ, Richter MK, Smit JM, Fremont DH, Pierson TC, Heise MT, Diamond MS.

PLoS Pathog. 2013;9(4):e1003312. doi: 10.1371/journal.ppat.1003312. Epub 2013 Apr 18.

14.

Cytomegalovirus infection impairs immune responses and accentuates T-cell pool changes observed in mice with aging.

Cicin-Sain L, Brien JD, Uhrlaub JL, Drabig A, Marandu TF, Nikolich-Zugich J.

PLoS Pathog. 2012;8(8):e1002849. doi: 10.1371/journal.ppat.1002849. Epub 2012 Aug 16.

15.

A temporal role of type I interferon signaling in CD8+ T cell maturation during acute West Nile virus infection.

Pinto AK, Daffis S, Brien JD, Gainey MD, Yokoyama WM, Sheehan KC, Murphy KM, Schreiber RD, Diamond MS.

PLoS Pathog. 2011 Dec;7(12):e1002407. doi: 10.1371/journal.ppat.1002407. Epub 2011 Dec 1.

16.

Interferon regulatory factor-1 (IRF-1) shapes both innate and CD8(+) T cell immune responses against West Nile virus infection.

Brien JD, Daffis S, Lazear HM, Cho H, Suthar MS, Gale M Jr, Diamond MS.

PLoS Pathog. 2011 Sep;7(9):e1002230. doi: 10.1371/journal.ppat.1002230. Epub 2011 Sep 1.

17.

The interferon-inducible gene viperin restricts West Nile virus pathogenesis.

Szretter KJ, Brien JD, Thackray LB, Virgin HW, Cresswell P, Diamond MS.

J Virol. 2011 Nov;85(22):11557-66. doi: 10.1128/JVI.05519-11. Epub 2011 Aug 31.

18.

In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection.

de Alwis R, Beltramello M, Messer WB, Sukupolvi-Petty S, Wahala WM, Kraus A, Olivarez NP, Pham Q, Brien JD, Tsai WY, Wang WK, Halstead S, Kliks S, Diamond MS, Baric R, Lanzavecchia A, Sallusto F, de Silva AM.

PLoS Negl Trop Dis. 2011 Jun;5(6):e1188. doi: 10.1371/journal.pntd.0001188. Epub 2011 Jun 21. Erratum in: PLoS Negl Trop Dis. 2011 Aug;5(8). doi: 10.1371/annotation/f585335f-ff77-40ae-a8b6-ad6019af31aa. Brian, James [corrected to Brien, James D].

19.

Repeated in vivo stimulation of T and B cell responses in old mice generates protective immunity against lethal West Nile virus encephalitis.

Uhrlaub JL, Brien JD, Widman DG, Mason PW, Nikolich-Zugich J.

J Immunol. 2011 Apr 1;186(7):3882-91. doi: 10.4049/jimmunol.1002799. Epub 2011 Feb 21.

20.

Genotype-specific neutralization and protection by antibodies against dengue virus type 3.

Brien JD, Austin SK, Sukupolvi-Petty S, O'Brien KM, Johnson S, Fremont DH, Diamond MS.

J Virol. 2010 Oct;84(20):10630-43. doi: 10.1128/JVI.01190-10. Epub 2010 Aug 11.

21.

Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2.

Sukupolvi-Petty S, Austin SK, Engle M, Brien JD, Dowd KA, Williams KL, Johnson S, Rico-Hesse R, Harris E, Pierson TC, Fremont DH, Diamond MS.

J Virol. 2010 Sep;84(18):9227-39. doi: 10.1128/JVI.01087-10. Epub 2010 Jun 30.

22.

The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1.

Shrestha B, Brien JD, Sukupolvi-Petty S, Austin SK, Edeling MA, Kim T, O'Brien KM, Nelson CA, Johnson S, Fremont DH, Diamond MS.

PLoS Pathog. 2010 Apr 1;6(4):e1000823. doi: 10.1371/journal.ppat.1000823.

23.
24.

Key role of T cell defects in age-related vulnerability to West Nile virus.

Brien JD, Uhrlaub JL, Hirsch A, Wiley CA, Nikolich-Zugich J.

J Exp Med. 2009 Nov 23;206(12):2735-45. doi: 10.1084/jem.20090222. Epub 2009 Nov 9.

25.

West nile virus capsid degradation of claudin proteins disrupts epithelial barrier function.

Medigeshi GR, Hirsch AJ, Brien JD, Uhrlaub JL, Mason PW, Wiley C, Nikolich-Zugich J, Nelson JA.

J Virol. 2009 Jun;83(12):6125-34. doi: 10.1128/JVI.02617-08. Epub 2009 Apr 15.

26.
27.

Cutting edge: TLR ligands increase TCR triggering by slowing peptide-MHC class I decay rates.

Rudd BD, Brien JD, Davenport MP, Nikolich-Zugich J.

J Immunol. 2008 Oct 15;181(8):5199-203.

28.

Age-related dysregulation of CD8+ T cell memory specific for a persistent virus is independent of viral replication.

Lang A, Brien JD, Messaoudi I, Nikolich-Zugich J.

J Immunol. 2008 Apr 1;180(7):4848-57.

29.

Protective capacity and epitope specificity of CD8(+) T cells responding to lethal West Nile virus infection.

Brien JD, Uhrlaub JL, Nikolich-Zugich J.

Eur J Immunol. 2007 Jul;37(7):1855-63.

30.

Activation of virus-specific CD8+ T cells by lipopolysaccharide-induced IL-12 and IL-18.

Raué HP, Brien JD, Hammarlund E, Slifka MK.

J Immunol. 2004 Dec 1;173(11):6873-81.

31.

Antiviral T-cell-independent type 2 antibody responses induced in vivo in the absence of T and NK cells.

Szomolanyi-Tsuda E, Brien JD, Dorgan JE, Garcea RL, Woodland RT, Welsh RM.

Virology. 2001 Feb 15;280(2):160-8.

32.

The role of CD40-CD154 interaction in antiviral T cell-independent IgG responses.

Szomolanyi-Tsuda E, Brien JD, Dorgan JE, Welsh RM, Garcea RL.

J Immunol. 2000 Jun 1;164(11):5877-82.

Supplemental Content

Loading ...
Support Center